Manipal Health shares list at 11% premium to beat GMP estimates. What should allotted investors do?

Manipal Health Enterprises shares debuted at an 11% premium over the IPO price, beating grey market expectations. Brokerages remain constructive on the hospital chain's long-term prospects, though some caution that valuations are rich. Here's what experts recommend for allotted investors and those considering fresh entry.

Raccontata daeconomictimes.indiatimes.comasiabusinessoutlook.comasia.nikkei.comthehindubusinessline.com